Gapping up
In reaction to strong earnings/guidance: SKYS +12.5%, FNSR +10.4%, SWHC +9.7%, MGM +2.4%, ORCL +1.8%, ITI +0.8%
M&A news: RDEN +48% (Elizabeth Arden to be acquired by Revlon for $14.00 Per Share in All-Cash Transaction), REV +0.5%
Select financial related names showing strength: BCS +4.3%, LYG +4.2%, RBS +3.7%, DB +3.3%, CS +2.5%
Select metals/mining stocks trading higher: CLF +3.8%, MUX +3.3%, AG +2.9%, CDE +2.8%, FCX +2.7%, MT +2%, HMY +1.8%, ABX +1.7%, SLV +1.5%, BBL +1.4%
Select oil/gas related names showing strength: WLL +5.1%, CHK +4%, RIG +2.3%, RDS.A +1%
Other news: PRTK +16.8% ( Announces that Omadacycline met all Primary and Secondary outcomes), GBSN +14.5% (unveils news analyzer, the GB550, at the ASM Microbe 2016; expects to begin delivery of the new analyzer in 1H17), LL +12.2% (CPSC announced that LL agreed to not resume sales of inventory of Chinese-made laminate flooring ), LOCK +5.4% (Elliott Associates discloses 8.8% active stake), BMRN +4.3% (shares ticking higher pre-market after Betaville reports that Sanofi (SNY) could look to acquire it if its pending pursuit of Medivation (MDVN) fails), BIOS +1.4% (prices offering of 40 mln shares of common stock at $2.00 per share), VRX +1.2% (Canadian subsidiary is expanding manufacturing & export capacity with investments totaling $27.5 mln)
Analyst comments: GEVO +7.6% (positive commentary at Rodman & Renshaw), SYRG +2.5% (initiated with a Strong Buy at Raymond James), CRZO +1.5% (initiated with Buy at Stifel), PM +1% (upgraded to Overweight at JP Morgan)